Taken together, our results suggest that both PD-L1 and TACS affect the likelihood of tumour-immune escape, with PD-L1 having a greater impact on TACS1→TACS2/EMT− tumours compared with TACS1→TACS2→TACS3/EMT + tumours. Here, CD274 is linked to neoplasm.